TY - JOUR
T1 - Bridging the academic-industrial gap
T2 - Application of an oxygen and pH sensor-integrated lab-on-a-chip in nanotoxicology
AU - Zirath, Helene
AU - Spitz, Sarah
AU - Roth, Doris
AU - Schellhorn, Tobias
AU - Rothbauer, Mario
AU - Müller, Bernhard
AU - Walch, Manuel
AU - Kaur, Jatinder
AU - Wörle, Alexander
AU - Kohl, Yvonne
AU - Mayr, Torsten
AU - Ertl, Peter
N1 - Funding Information:
This work was funded by the Austrian Research Promotion Agency (FFG; 869173), by the European Union's Marie Skłodowska-Curie Action (823981) and by the Fonds National de la Recherche (FNR) Luxembourg in the M-era Net project NanoPD (INTER/MERA/17/11760144). The authors acknowledge the TU Wien University Library for financial support through its Open Access Funding Program. Schematics were created using BioRender.com.
Publisher Copyright:
© The Royal Society of Chemistry.
PY - 2021/11/7
Y1 - 2021/11/7
N2 - Translation of advanced cell-based assays exhibiting a higher degree of automation, miniaturization, and integration of complementary sensing functions is mainly limited by the development of industrial-relevant prototypes that can be readily produced in larger volumes. Despite the increasing number of academic publications in recent years, the manufacturability of these microfluidic cell cultures systems is largely ignored, thus severely restricting their implementation in routine toxicological applications. We have developed a dual-sensor integrated microfluidic cell analysis platform using industrial specifications, materials, and fabrication methods to conduct risk assessment studies of engineered nanoparticles to overcome this academic-industrial gap. Non-invasive and time-resolved monitoring of cellular oxygen uptake and metabolic activity (pH) in the absence and presence of nanoparticle exposure is accomplished by integrating optical sensor spots into a cyclic olefin copolymer (COC)-based microfluidic platform. Results of our nanotoxicological study, including two physiological cell barriers that are essential in the protection from exogenous factors, the intestine (Caco-2) and the vasculature (HUVECs) showed that the assessment of the cells' total energy metabolism is ideally suited to rapidly detect cytotoxicities. Additional viability assay verification using state-of-the-art dye exclusion assays for nanotoxicology demonstrated the similarity and comparability of our results, thus highlighting the benefits of employing a compact and cost-efficient microfluidic dual-sensor platform as a pre-screening tool in nanomaterial risk assessment and as a rapid quality control measure in medium to high-throughput settings.
AB - Translation of advanced cell-based assays exhibiting a higher degree of automation, miniaturization, and integration of complementary sensing functions is mainly limited by the development of industrial-relevant prototypes that can be readily produced in larger volumes. Despite the increasing number of academic publications in recent years, the manufacturability of these microfluidic cell cultures systems is largely ignored, thus severely restricting their implementation in routine toxicological applications. We have developed a dual-sensor integrated microfluidic cell analysis platform using industrial specifications, materials, and fabrication methods to conduct risk assessment studies of engineered nanoparticles to overcome this academic-industrial gap. Non-invasive and time-resolved monitoring of cellular oxygen uptake and metabolic activity (pH) in the absence and presence of nanoparticle exposure is accomplished by integrating optical sensor spots into a cyclic olefin copolymer (COC)-based microfluidic platform. Results of our nanotoxicological study, including two physiological cell barriers that are essential in the protection from exogenous factors, the intestine (Caco-2) and the vasculature (HUVECs) showed that the assessment of the cells' total energy metabolism is ideally suited to rapidly detect cytotoxicities. Additional viability assay verification using state-of-the-art dye exclusion assays for nanotoxicology demonstrated the similarity and comparability of our results, thus highlighting the benefits of employing a compact and cost-efficient microfluidic dual-sensor platform as a pre-screening tool in nanomaterial risk assessment and as a rapid quality control measure in medium to high-throughput settings.
UR - http://www.scopus.com/inward/record.url?scp=85118177124&partnerID=8YFLogxK
U2 - 10.1039/d1lc00528f
DO - 10.1039/d1lc00528f
M3 - Article
C2 - 34605521
AN - SCOPUS:85118177124
VL - 21
SP - 4237
EP - 4248
JO - Lab on a chip - miniaturisation for chemistry and biology
JF - Lab on a chip - miniaturisation for chemistry and biology
SN - 1473-0197
IS - 21
ER -